| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 02/02/2005 | EP1501838A1 A process for the preparation of clopidogrel |
| 02/02/2005 | EP1501832A1 Triazolopyrimidines |
| 02/02/2005 | EP1501507A2 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 02/02/2005 | EP1235574B1 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 02/02/2005 | CN1187354C Adenosine receptor antagonists and methods of making and using the same |
| 01/27/2005 | WO2004092181A9 Heterocyclic mchr1 antagonists |
| 01/27/2005 | WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 01/27/2005 | US20050020598 Antiserotonine agents; central nervous system disorders; anxiolytic agents; cognition activators; schizophrenia ; antidepressants; Alzheimer's disease; Parkinson's disease |
| 01/27/2005 | US20050020574 dipeptidylpeptidase-IV inhibitors; treatment of diabetes and obesity |
| 01/26/2005 | EP1499622A1 Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors |
| 01/26/2005 | EP1499621A1 Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors |
| 01/26/2005 | EP1499620A1 Process for preparing 6-alkylidene penem derivatives |
| 01/26/2005 | EP1499308A2 Tri-substituted heteroaryls and methods of making and using the same |
| 01/26/2005 | CN1571788A Photoactivable nitrogen bases |
| 01/20/2005 | WO2005005432A1 Novel 2,7-dioxo-bicyclo[4.3.0]non-5-yl-urea derivatives |
| 01/20/2005 | WO2003076443A9 Spiro compounds with npy antagonistic activity |
| 01/20/2005 | US20050014761 Antitumor agents; antiancer agents; antiinflammatory agents; autoimmune disease |
| 01/20/2005 | US20050014760 Methods of treating diseases or conditions using dihydropteridinone compounds |
| 01/20/2005 | US20050014700 Cbi analogues of cc-1065 and the duocarmycins |
| 01/19/2005 | EP1497287A1 Quinolinone derivatives |
| 01/19/2005 | EP1496903A1 Anhydrovinblastine for the treatment of cancer |
| 01/19/2005 | EP1496896A1 Inhibitors of akt activity |
| 01/13/2005 | US20050009849 Pyridopyrimidine kinase inhibitors |
| 01/12/2005 | EP1495022A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 01/12/2005 | EP1494676A1 Fused quinoxaline derivatives as inhibitors of akt activity |
| 01/11/2005 | US6841677 For use as semiconductors or charge transport materials in optical, electrooptical or electronic devices including field effect transistors, electroluminescent, photovoltaics, sensors and electrophotographic recording devices |
| 01/11/2005 | US6841567 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/06/2005 | WO2005000852A2 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 01/06/2005 | WO2005000814A1 Polymethine ethers |
| 01/06/2005 | WO2004096800A3 Quinuclidine derivatives binding to mucarinic m3 receptors |
| 01/06/2005 | US20050004153 inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); use treating transplant rejection, rheumatoid arthritis, diabetes, inflammatory bowel disease, and chronic obstructive pulmonary disease; 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 01/06/2005 | US20050004142 furo(2,3-d)pyrimidine and thieno(2,3-d)pyrimidine compounds for treating cancer and hyperproliferative diseases; receptor tyrosine kinase inhibitors |
| 01/06/2005 | US20050004128 4-(6-chloro-, methyl- or thien-3-yl-oxazolo[4,5-b]pyrid-2-yl)-1,4-diazabicyclo[3.2.2]nonane or salts; nicotinic receptor associated disorders; cholinergic agents |
| 01/06/2005 | US20050004026 Induction of capacse cascade ; administering apoptosis inducing protein; drug screening; anticancer agents |
| 01/06/2005 | CA2530668A1 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 01/05/2005 | EP1493057A1 Colour photographic recording material |
| 01/05/2005 | EP1492803A1 New analogs of nitrobenzylthioinosine |
| 01/05/2005 | EP1492789A1 Tropane derivatives as ccr5 modulators |
| 01/05/2005 | EP1492571A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 01/05/2005 | DE10327439A1 Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel New Imidazopyridazinon- and Imidazopyridonderivate, their preparation and their use as medicaments |
| 01/05/2005 | CN1560060A Synthesis for compound of diamine bridge linking ortho phenanthroline hydrous lanthanum (III) and anti-cancer activity thereof |
| 01/05/2005 | CN1183129C Condensed azepines as vasporession agonists |
| 01/04/2005 | US6838459 7-alkyl-and cycloalkyl-substituted imidazotriazinones |
| 12/30/2004 | US20040266860 Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents |
| 12/30/2004 | US20040266666 Cross-linked glycopeptide-cephalosporin antibiotics |
| 12/29/2004 | WO2004113350A1 Cross-linked glycopeptide - cephalosporin antibiotics |
| 12/29/2004 | EP1490374A2 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases |
| 12/29/2004 | EP1490344A2 Anxiolytic agents with reduced sedative and ataxic effects |
| 12/28/2004 | CA2105923C 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives |
| 12/23/2004 | WO2004111054A1 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors |
| 12/23/2004 | WO2004111051A1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments |
| 12/23/2004 | WO2004110990A2 Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38 |
| 12/23/2004 | WO2004091482A3 M3 muscarinic acetylcholine receptor antagonists |
| 12/23/2004 | US20040259907 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents |
| 12/23/2004 | US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 12/23/2004 | US20040259888 Antiischemic agents; cardiovascular disorders; analgesics; neurodegenerative disease |
| 12/23/2004 | CA2529729A1 New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 12/23/2004 | CA2526285A1 Inhibitors of p38 and methods of using the same |
| 12/22/2004 | EP1489084A1 Broad-spectrum cephem compounds |
| 12/22/2004 | CN1181075C Pyrimidine-4-keto compound, its preparation method and medicine composition containing them |
| 12/22/2004 | CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same |
| 12/21/2004 | US6833455 Coloring plastics |
| 12/16/2004 | WO2004108728A1 Cannabinoid receptor ligands and uses thereof |
| 12/16/2004 | WO2004107863A1 Sustituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands |
| 12/16/2004 | US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 12/16/2004 | CA2525752A1 Cannabinoid receptor ligands and uses thereof |
| 12/16/2004 | CA2524376A1 Substituted imidazolopyrazine and triazolopyrazyne derivatives: gabaa receptor ligands |
| 12/15/2004 | EP1485389A1 Antiparasitic artemisinin derivatives (endoperoxides) |
| 12/15/2004 | EP1485387A1 Carbamates as hiv protease inhibitors |
| 12/15/2004 | CN1554656A Yunnan tolal biological coronaridine and its salts and preparing method and use |
| 12/14/2004 | US6831075 Heterocyclic substituted pyrazolones |
| 12/14/2004 | US6830836 Heterocyclic compounds, materials for light emitting devices and light emitting devices using the same |
| 12/09/2004 | WO2004092173A3 A2a adenosine receptor antagonists |
| 12/09/2004 | US20040249152 Activation of the carboxyl function of a CNA monomer building block, subsequent esterification of this monomer building block with a free hydroxyl function,thereafter assembly of the oligomer by repetitive cycles starting from elimination of the protective group |
| 12/09/2004 | US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 12/09/2004 | US20040248907 reacting 4,6-dichloro-5-nitropyrimidine with acyclic carboxy amines, then cyclization of the intermediates to form cellular adhesion inhibitors |
| 12/09/2004 | US20040248881 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders |
| 12/08/2004 | EP1483270A1 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase |
| 12/08/2004 | EP1483266A1 Spiro compounds with npy antagonistic activity |
| 12/08/2004 | EP1483265A1 Purine derivatives as kinase inhibitors |
| 12/08/2004 | EP1483264A2 1-allyl ergot alkaloid derivatives, method for producing the same and the use thereof for preventing and treating migraine |
| 12/08/2004 | EP1483257A1 Quinazoline compounds useful in therapy |
| 12/08/2004 | EP1482971A1 Strategy for retroviral immunotherapy |
| 12/08/2004 | EP1482933A2 Potent, simplified derivatives of immunosuppressive agents |
| 12/08/2004 | CN1552716A Synthesis of vinorelbine |
| 12/08/2004 | CN1552715A Preparation of dehydrate catharahhine from intermediate of vinorelbine synthesis |
| 12/07/2004 | US6828330 Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| 12/07/2004 | CA2272136C Pyrazole derivatives having crf antagonist activity |
| 12/07/2004 | CA2147755C 6-(substituted methylene) penems and intermediates |
| 12/02/2004 | WO2004104008A1 PROCESS FOR SYNTHESIZING β-LACTAMASE INHIBITOR INTERMEDIATES |
| 12/02/2004 | WO2004104004A2 Triaza-spiro compounds as nociceptin analogues and uses thereof |
| 12/02/2004 | WO2004104001A2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| 12/02/2004 | US20040242884 3-Substituted-7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; for herpes viruses |
| 12/02/2004 | US20040242867 Photoinitiators; basic catalyst; absorption of light |
| 12/02/2004 | CA2532059A1 Triaza-spiro compounds as nociceptin analogues and uses thereof |
| 12/02/2004 | CA2525507A1 Process for synthesizing .beta.-lactamase inhibitor intermediates |
| 12/02/2004 | CA2525504A1 Process for synthesizing .beta.-lactamase inhibitor in intermediates |
| 12/01/2004 | EP1481077A2 Mitotic kinesin inhibitors |
| 12/01/2004 | EP1480983A1 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives |
| 12/01/2004 | EP1480979A2 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates |